Genetically-engineered (GE) products are highly politicized in Germany. Despite an openness to innovation, agricultural biotechnology faces significant challenges in Germany due to mixed societal and governmental attitudes. Regulatory frameworks, shaped by EU directives, heavily influence Germany's approach to biotechnology, including stringent approval processes and trade barriers. The newly formed coalition government, composed of the Christian Democratic Union (CDU) and Social Democratic Party (SPD), has yet to establish a unified position on New Genomic Techniques (NGTs), reflecting internal divisions within the governing parties. Recent studies indicate a gradual shift in public opinion, with some surveys showing increased acceptance of New Genomic Techniques, particularly among older demographics. However, other surveys highlight continued strong consumer demand for labeling and traceability of products derived from these techniques.